Pablo Valenzuela, vice president of R & D at Chiron Corp, there are several options for how to allocate scarce resources to more promising projects. These elections will determine the position of Chiron in the number of new biotechnology and diagnostic markets, including tests for hepatitis C, HIV, and others. Valenzuela should explore the potential of Chiron, strategy, and character features, including the impact of the elections on the joint venture partners. "Hide
by Stephen S. Kolesnik, Brian Elliott Source: Harvard Business School 20 pages. Publication Date: April 16, 1993. Prod. #: 693052-PDF-ENG
Related Case Solutions & Analyses:
Husk Power
SAP: The Challenge of Aligning Sourcing and Innovation Strategies
Indonesia: Growth and Stability in a Global Economy
80 Hudson Vinegar Hill-DUMBO Brooklyn
Motorola’s Spin-Off of Its Cell Phone Business
Reawakening the World’s Most Famous Office Building: Economics behind a Groundbreaking Energy Efficiency Retrofit
Shepard Quraeshi Associates (A)
Argentina’s YPF Sociedad Anonima (Abridged)
Note on Privatization in Brazil
Power Across Latin America: Endesa de Chile
